Gene · 3039
Papers3,980
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,980
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Proteomic analysis of lacrimal gland adenoid cystic carcinoma with high-grade transformation]. | Zhonghua Yan Ke Za Zhi | 2021 | 34256474 | PubTator, text mining | PubMed |
| Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response. | Br J Cancer | 2021 | 34253873 | PubTator, text mining | PubMed |
| Breakpoint characterization of a rare alpha0 -thalassemia deletion using targeted locus amplification on genomic DNA. | Int J Lab Hematol | 2021 | 34251753 | PubTator, text mining | PubMed |
| Multiple linear regression models for predicting the n‑octanol/water partition coefficients in the SAMPL7 blind challenge. | J Comput Aided Mol Des | 2021 | 34251523 | PubTator, text mining | PubMed |
| Proteomic and Biological Analysis of an In Vitro Human Endothelial System in Response to Drug Anaphylaxis. | Front Immunol | 2021 | 34248989 | PubTator, text mining | PubMed |
| Low testosterone and cardiometabolic risks in a real-world study of US male firefighters. | Sci Rep | 2021 | 34244582 | PubTator, text mining | PubMed |
| Glycosylated Hemoglobin as a Predictor of Sepsis and All-Cause Mortality in Trauma Patients. | Infect Drug Resist | 2021 | 34234479 | PubTator, text mining | PubMed |
| High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion. | EMBO Mol Med | 2021 | 34232570 | PubTator, text mining | PubMed |
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia. | Br J Haematol | 2021 | 34227124 | PubTator, text mining | PubMed |
| A serum proteome signature to predict mortality in severe COVID-19 patients. | Life Sci Alliance | 2021 | 34226277 | PubTator, text mining | PubMed |
| Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision. | Elife | 2021 | 34225842 | PubTator, text mining | PubMed |
| Image Analysis Using Machine Learning for Automated Detection of Hemoglobin H Inclusions in Blood Smears - A Method for Morphologic Detection of Rare Cells. | J Pathol Inform | 2021 | 34221634 | PubTator, text mining | PubMed |
| Evaluation of the Genetic Association and Expressions of Notch-2 /Jagged-1 in Patients with Type 2 Diabetes Mellitus. | Med Arch | 2021 | 34219868 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis. | BMC Cardiovasc Disord | 2021 | 34218797 | PubTator, text mining | PubMed |
| 'Magnesium'-the master cation-as a drug-possibilities and evidences. | Biometals | 2021 | 34213669 | PubTator, text mining | PubMed |
| Dissecting human trophoblast cell transcriptional heterogeneity in preeclampsia using single-cell RNA sequencing. | Mol Genet Genomic Med | 2021 | 34212522 | PubTator, text mining | PubMed |
| A Computational-Based Drug Repurposing Method Targeting SARS-CoV-2 and its Neurological Manifestations Genes and Signaling Pathways. | Bioinform Biol Insights | 2021 | 34211268 | PubTator, text mining | PubMed |
| Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour. | Cancers (Basel) | 2021 | 34209558 | PubTator, text mining | PubMed |
| High-Resolution Cartography of the Transcriptome and Methylome Landscapes of Diffuse Gliomas. | Cancers (Basel) | 2021 | 34206856 | PubTator, text mining | PubMed |
| Ferryl Hemoglobin and Heme Induce A1-Microglobulin in Hemorrhaged Atherosclerotic Lesions with Inhibitory Function against Hemoglobin and Lipid Oxidation. | Int J Mol Sci | 2021 | 34206377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3039/papers?page=54